Critical Path Institute
Analysis
Critical Path Institute is a registered charity in United States, based in Tucson, AZ. It received its IRS tax-exemption ruling in May 2005, 21 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending June 2023, Critical Path Institute reported income of $35.3m and spending of $32.0m, spending 91% of its income. Across the 5 years on record, from June 2019 to June 2023, income grew from $16.8m to $35.3m (+110%), an average of +20% a year. The sharpest change came in the year to June 2021, when income rose by 32%. Over the whole period it spent 93% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Critical Path Institute sits at the 91st percentile: it is larger than about 91% of them. Against every charity in United States with reported income it ranks in the 98th percentile, and in the 98th percentile within AZ. Charities of a similar size with the same main cause include Lexmed Inc ($35.2m), Crossroads Inc ($35.3m) and Quality Living Inc ($35.2m).
On its Form 990 for the period ending June 2023, revenue came from contributions and grants 67% and program service revenue 32% of the total. Compensation of current officers, directors and key employees was $2.5m (8.0% of expenses). Other salaries and wages came to $13.7m. At year end it held assets of $26.7m against liabilities of $11.5m, net assets of $15.3m. It reported 176 employees.
Income and spending
Where the income comes from
- Contributions & grants 67%
- Program services 32%
- Other 1.2%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Lexmed Inc | Lexington | $35.2m |
| Crossroads Inc | Phoenix | $35.3m |
| Quality Living Inc | Omaha | $35.2m |
| American Urological Association Education and Research Inc | Linthicum | $35.4m |